The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 1/9

Austrian Health and Pharma Headlines

Sanochemia to Look for New Skin Cancer Treatment with US Company

Pharmaceutical company Sanochemia listed in Vienna and Frankfurt announced that it is going to cooperate with the US company Newfield at the University of Graz on the search for cancer treatment.

July 18, 2016

Valneva Biotech to Book first Revenues from Flu Vaccine

French-Austrian vaccine maker Valneva booked the first revenues from its flu vaccine, Valneva said. British pharmacy group GlaxoSmithKline delivered the first time the vaccines produced on Valneva's EB66 cell line. The licence payments for the E66-based vaccine will start this year.

June 13, 2016

Valneva Share Nosedived after Announcement about Clinical Studies into New Vaccine

Following the publication of the unsatisfactory outcome of clinical studies of a new vaccine, Valneva saw its share price cave in over 20 percent the morning after. The pharmaceutical company is listed on Vienna Stock Exchange and its share price plummeted to about EUR 2.60 (USD 2.914) at 9.15.

June 6, 2016

Biogena Wants to Expand Globally

Biogena, producer of supplements with headquarters in the City of Salzburg wants to expand. In the coming months up to 20 shops will be opened in big German cities. Moreover, the company wants to launch distribution in France, the owner of the company, Albert Schmidbauer, announced during the opening of the new company headquarters in Salzburg.

May 13, 2016

Boehringer Ingelheim Pharma Austrian Unit Ups 2015 Revenues

German pharma group Boehringer Ingelheim raised revenues by 5.5 percent to EUR 760.2 million (USD 861.5 million) in Austria as well as over 30 countries supervised from Vienna in 2015, the company said. Operating performance grew by 2.4 percent y/y to EUR 1.14 billion.

April 20, 2016

Life Sciences Field is Booming in Vienna

Nine percent revenue growth, five percent increase in the workforce and a large increase in business startups - Vienna as a location for life science businesses is attracting companies at a rate never seen before.

October 14, 2015

Antibiotics Company Nabriva Therapeutics Collects USD 120 Mln from Investors

Viennese biotech firm Nabriva Therapeutics, specialized in antibiotics against resistant bacteria, has collected USD 120 million from investors. The financing process took two tranches, law firm Wolf Theiss, which advised investors together with US firm Cooley, announced on Wednesday.

April 9, 2015

Vamed to Manage First Hospital in China

Vamed is about to establish and manage its first hospital in China - in the provincial capital Haikou on the island of Hainan.

March 30, 2015

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015

Pfizer's Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines Includes Facility in Austria

Pfizer Inc. announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.

August 1, 2014